Thursday, January 8, 2009

Medegen Receives FDA Clearance for MaxGuard Advanced Luer-Activated Device with Antimicrobial Technology

Jan 8, 2009 - Medegen, a leading innovator in infusion therapy products, today announced that it has received 510(k) clearance from the U.S. FDA for its new MaxGuard Advanced Luer Activated Device featuring Agion Antimicrobial Technology. MaxGuard is the first positive displacement needleless connector featuring impregnation of the antimicrobial additive into each of the components of the device.

The details can be read here.

No comments: